PATENT CLAIM ANALYSIS

Application Number: 15862922
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "489000"]

Abstract:
The present disclosure provides ready-to-use, oil/water emulsion compositions with mean droplet size (intensity-average, nm) of 100-500 nm, where the oil phase comprises clopidogrel free base dispersed in pharmaceutical acceptable oil(s). The emulsion uses clopidogrel free base or premix of clopidogrel free base in oil(s) as the starting materials and may also contain one or more excipients such as surfactant and or co-surfactant, osmotic agent, pH adjustment agent, antioxidant, preservative, sweetener, and/or suspending agent, etc.

Claim (Index 2):
The method of  claim 1 , wherein clopidogrel free base is obtained by converting clopidogrel salt to free base and separating counter ion from the free base.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.59322
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14174351', '14623150', '15454967', '12597908', '11738444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7077521745303662
- 35 USC 102 Novelty (BERT): 0.551163846391393
- Combined Prediction Score: 0.6920933417164689
- Mean Citation Score: 261.730012
- Max Citation Score: 393.54953
- Similarity Product: 328.4332976519668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test